Structured Non-operative Treatment of Knee Osteoarthritis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01535001 |
|
Recruitment Status :
Completed
First Posted : February 17, 2012
Results First Posted : January 27, 2016
Last Update Posted : October 16, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
The purpose of this study is to test whether an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, non steroidal anti inflammatory drugs (NSAIDs) and Pantoprazole provides further improvement in pain, function and quality of life than standard non-surgical treatment (information on the disease and how to treat it) in patients with knee osteoarthritis.
The H1-hypothesis is that the treatment algorithm results in a greater increase in quality of life and functional capacity and greater reduction in pain than standard treatment at the primary endpoint, which is follow-up 12months after the start of the treatment.
See statistical analysis plan available under "Links" for further description of the study.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Osteoarthritis of the Knee | Other: Neuromuscular training (NEMEX-TJR) Behavioral: Information Drug: Paracetamol Drug: Burana Drug: Pantoprazole Behavioral: Dietary counseling Behavioral: Patient education Other: Insoles | Not Applicable |
Knee osteoarthritis (OA) is the degenerative joint disease that most often requires treatment and at the same time the one associated with the greatest social costs. In addition, the disease has many personal costs and is greatly contributing to reduced functionality and autonomy of older adults.
It is recommended both nationally and internationally that the treatment of knee osteoarthritis should include multiple treatment modalities. Clinical guidelines recommend that exercise, weight loss and patient education is the first step in treatment and that insoles and pharmacological treatment can be included as a supplement.
However if the patient is not a candidate for total knee replacement, the patient most often receives only information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse. This postponement of treatment can lead to a worsening of pain and function and a worse outcome after treatment. Therefore, the current treatment strategy for the patient group is problematic.
The current practice may be due to the lack of studies with high level of evidence that have examined the optimal non-operative treatment approach and compared it with the current standard treatment for this group of patients.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Structured Non-operative Treatment of Knee Osteoarthritis - a Randomized Controlled Trial of Pain, Physical Function and Quality of Life With 12months Follow-up |
| Study Start Date : | February 2012 |
| Actual Primary Completion Date : | September 2014 |
| Actual Study Completion Date : | September 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: MEDIC
Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.
|
Other: Neuromuscular training (NEMEX-TJR)
60min. of neuromuscular training two times a week for 3 months (12 weeks) using the neuromuscular training program called NEMEX-TJR.
Other Name: No other Drug: Paracetamol 1 g x 4/day
Other Name: No other Drug: Burana 400 mg x 3/day for three weeks
Other Name: No other Drug: Pantoprazole 20mg x 1/day for three weeks
Other Name: No other Behavioral: Dietary counseling For participants with a BMI equal to or >25. The dietitian initiates a 3-month intervention that provides instruction and guidance in relation to diet and plans the number of visits according to the individual participant needs.
Other Name: No other Behavioral: Patient education The aim is to strengthen the participant's involvement in the treatment, so the participant will be in a position to handle, master and act reasonable in relation to their knee OA. This aspect of the intervention is based on principles from The Chronic Disease Self-Management Program, "Lær at leve med kronisk sygdom (Learn to live with chronic illness)" by The National Board of Health, Denmark and "Artrosskolan Spenshult" in Sweden.
Other Name: No other Other: Insoles The position of the knee is assessed using Single Leg Mini Squat. On the basis of this test it is decided which of two types of insoles (Formthotics System) the participant should have (neutral with a lateral wedge or neutral). The participants will be advised to use the insoles in all shoes. Other Name: No other |
|
Active Comparator: Standard treatment
Information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse.
|
Behavioral: Information
Information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse. Information will be given in a leaflet. Other Name: No other |
- Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score) [ Time Frame: Primary: 12months. ]
The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best).
Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysis will be made using a mixed model ANOVA with subject being a random factor and visit (baseline, 3, 6 and 12 months), treatment arm (TKA + MEDIC, MEDIC) and site (Frederikshavn, Farsoe) being fixed factors. Baseline KOOS4 will be a covariate. Furthermore interactions between the fixed factors will be included in the model. P-values and 95% CI will be presented to assess superiority.
- Change From Baseline in EQ-5D [ Time Frame: Primary: 12months. ]
Between groups comparisons of the change from baseline to the 1 year follow-up in all secondary endpoint will be handled similar to the primary endpoint. See statistical analysis plan for further description (available under "Links").
Range of EQ-5D Descriptive Index is -0.59 to 1.00 (worst to best), while the EQ VAS goes from 0 to 100 (worst to best).
- Change From Baseline in 20-meter Walk [ Time Frame: Primary: 12months. ]
- Change in the Five KOOS Subscale Scores From Baseline [ Time Frame: Primary: 12 months. ]Range of all subscales are 0 to 100 (worst to best).
- Weight Change in kg From Baseline [ Time Frame: Primary: 12months. ]Weight change in kg measured without shoes at the same time of day and on the same scale
- Proportion of Users of Pain Medication [ Time Frame: Baseline and 12months. ]With possible answers being yes and no
- Number of Serious Adverse Events Reported at Index Knee [ Time Frame: Primary: 12months. ]Adverse events (AE) and seriously adverse events (SAE) will be registered in three ways and divided into index knee or sites other than index knee. The project physiotherapist will record any adverse events that the participant experiences or tells them about. For the participants allocated to, or crossing over to, TKA, a project worker will look through hospital records to register if any pre-defined perioperative and postoperative adverse events occurred. At all follow-ups, the assessor will use open-probe questioning to assess adverse events in all participants.
- Change From Baseline in Time From the Timed Up and Go [ Time Frame: Primary: 12 months. ]
- Exploratory Outcomes [ Time Frame: Baseline, 3months, 6months, 12months and 24months ]
- Pain intensities on a 100 mm VAS with terminal descriptors of 'no pain' and 'worst pain possible' in various situations.
- Number of sites with pain in the previous 24 hours shaded on a region-divided body chart
- Pain location and type assessed using the Knee Pain Map.
- Maximum isometric muscle strength measured bilaterally in knee flexion and knee extension in a make test using a handheld dynamometer (Powertrack II TM Commander).
- Pressure pain thresholds measured bilaterally using a handheld algometer (Algometer Type II) at five sites at the knee and the m. tibialis anterior muscle and the m. extensor carpi radialis longus.
- Postural balance assessed using an instrumented force platform (Good Balance), measuring the centre of pressure excursion.
- Self-efficacy in improving pain, function and QOL in various situations using a 100 mm VAS with terminal descriptors of 'very unsure' and 'very sure'.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Knee-OA detected by x-ray (Kellgren & Lawrence grade 1 or greater)
- KOOS4 of ≤ 75
- Considered not to be a candidate for Total Knee Replacement (TKR) by the orthopedic surgeon.
- The participant is > 18 years of age.
- The participant can provide relevant and adequate, informed consent.
Exclusion Criteria:
- Prior TKA ipsilateral
- Rheumatoid arthritis
- Mean VAS > 60mm the last week on a 0-100mm scale
- Possible pregnancy or planning pregnancy;
- Inability to comply with the protocol;
- Inadequacy in written and spoken Danish.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01535001
| Denmark | |
| Department of Occupational and Physiotherapy, Aalborg Hospital-Aarhus University Hospital | |
| Aalborg, Denmark, 9000 | |
| Farsoe Hospital | |
| Farsø, Denmark, 9640 | |
| Vendsyssel Hospital, Frederikshavn | |
| Frederikshavn, Denmark, 9900 | |
| Principal Investigator: | Søren T. Skou, PhD-student | Orthopaedic Research Unit, Aalborg University Hospital, Denmark | |
| Study Chair: | Ewa M. Roos, PhD | Research Unit for Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark | |
| Study Chair: | Lars Arendt-Nielsen, Dr.Sci.Med. | Center for Sensory-Motor Interaction (SMI), Department of Health Sciences and Technology, Aalborg University | |
| Study Chair: | Mogens B. Laursen, PhD | Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark | |
| Study Chair: | Sten Rasmussen, M.D. | Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark | |
| Study Chair: | Michael S. Rathleff, PhD-student | Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark | |
| Study Chair: | Ole H. Simonsen, Dr.Sci.Med. | Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Northern Orthopaedic Division, Denmark |
| ClinicalTrials.gov Identifier: | NCT01535001 |
| Other Study ID Numbers: |
N-20110085 |
| First Posted: | February 17, 2012 Key Record Dates |
| Results First Posted: | January 27, 2016 |
| Last Update Posted: | October 16, 2017 |
| Last Verified: | September 2017 |
|
Osteoarthritis, Knee Treatment Outcome Time Factors Rehabilitation Combined Modality Therapy Middle Aged |
Aged Aged, 80 and over Male Female Humans Analysis of Variance |
|
Osteoarthritis Osteoarthritis, Knee Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Acetaminophen Pantoprazole Analgesics, Non-Narcotic Analgesics |
Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Antipyretics Anti-Ulcer Agents Gastrointestinal Agents Proton Pump Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |